Experimental Screening for “Systemic Adjuvants of Immunity” Applicable in Cancer Immunotherapy

EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.

Howard E. Skipper, F. M. Schabel, W. S. Wilcox · PubMed · 1964 · 766 citations

Hematological Malignancy, Experimental Leukemia, Medicine +6

Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.

Foley Ej · PubMed · 1953 · 690 citations

Immunology, Pathology, Immunologic Mechanism +16

ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA

G Mathé, Jeanne Amiel, L Schwarzenberg et al. · The Lancet · 1969 · 612 citations

Immunosuppressive Therapy, Immunology, Hematology +6

Thymus-Marrow Cell Combinations. Synergism in Antibody Production.

Henry N. Claman, E A Chaperon, R. Faser Triplett · Experimental Biology and Medicine · 1966 · 609 citations

Cell Therapy, Normal Thymus, Laboratory Immunology +14

Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse

Lloyd J. Old, Donald A. Clarke, Baruj Benacerraf · Nature · 1959 · 524 citations

Xenotransplantation, Pathogenesis, Immunology +7